BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 17913694)

  • 1. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillator malfunction due to mechanical failure of the header connection.
    Pickett RA; Saavedra P; Ali MF; Darbar D; Rottman JN
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1095-9. PubMed ID: 15363086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B; Schernthaner C; Pichler M
    Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 9. [New aspects of defibrillator therapy].
    Brachmann J; Hilbel T; Beyer T; Schöls W; Karolyi L; Freigang K; Becker R; Bauer A; Kübler W
    Z Kardiol; 1996; 85 Suppl 6():83-9. PubMed ID: 9064987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate implantable cardioverter-defibrillator shock due to external alternating current leak: report of two cases.
    Chan NY; Wai-Ling Ho L
    Europace; 2005 Mar; 7(2):193-6. PubMed ID: 15763537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
    Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
    Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
    Adler A; Rosso R; Meir I; Viskin S
    Europace; 2013 Mar; 15(3):362-5. PubMed ID: 23118003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias.
    Bänsch D; Steffgen F; Grönefeld G; Wolpert C; Böcker D; Mletzko RU; Schöls W; Seidl K; Piel M; Ouyang F; Hohnloser SH; Kuck KH
    Circulation; 2004 Aug; 110(9):1022-9. PubMed ID: 15326069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator].
    Kühlkamp V; Dörnberger V; Mermi J; Mewis C; Seipel L
    Z Kardiol; 1996 May; 85(5):306-11. PubMed ID: 8711942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate sensing of pectoral myopotentials by an implantable cardioverter defibrillator system.
    Karanam S; John RM
    Pacing Clin Electrophysiol; 2004 May; 27(5):688-9. PubMed ID: 15125734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
    Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
    Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.